Disease management
The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.
The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.
The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.
The company will use the funds to accelerate its product expansion on a global scale.
The company is also recruiting a CEO in the US.
The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.
The aim is to expand Hello Heart's reach across patient populations by utilizing the Amwell platform.
A potentially shortened battery life in the MiniMed 600 or 700 series insulin pumps may result in the pump stopping insulin delivery significantly sooner than expected.
Also, Korean vision loss DTx Vivid Brain eyes global expansion.
The senior-focused mental health company will use the funds to expand its geographic footprint, form value-based care-payment models and enhance its technology.